Wellington Shields Capital Management’s Zimmer Biomet ZBH Stock Holding History

Wellington Shields Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-15,980	Closed	-$1.99M	–	338
2017 Q2	$1.99M	Sell	15,980 -613	-4%	-$72.7K	0.33%	74
2017 Q1	$1.97M	Buy	16,593 +31	+0.2%	+$3.51K	0.32%	73
2016 Q4	$1.66M	Sell	16,562 -1,339	-7%	-$144K	0.28%	83
2016 Q3	$2.26M	Hold	17,901	–	–	0.39%	59
2016 Q2	$2.09M	Buy	17,901 +15,686	+708%	+$1.78M	0.35%	62
2016 Q1	$229K	Hold	2,215	–	–	0.04%	279
2015 Q4	$221K	Hold	2,215	–	–	0.04%	278
2015 Q3	$202K	Hold	2,215	–	–	0.03%	282
2015 Q2	$235K	Hold	2,215	–	–	0.04%	304
2015 Q1	$253K	Hold	2,215	–	–	0.04%	296
2014 Q4	$244K	Hold	2,215	–	–	0.04%	300
2014 Q3	$216K	Sell	2,215 -20	-0.9%	-$1.97K	0.04%	317
2014 Q2	$225K	Sell	2,235 -10	-0.4%	-$976	0.04%	331
2014 Q1	$206K	Hold	2,245	–	–	0.04%	328
2013 Q4	$203K	Buy	+2,245	New	+$194K	0.04%	301

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Shields Capital Management's ZBH Position: Q3 2017 in Review

Wellington Shields Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2017, closing a stake of 15,980 shares — an estimated $1.99M sold.

Wellington Shields Capital Management first reported a position in ZBH in Q4 2013 and held it in 15 quarters. The position peaked at $2.26M in Q3 2016. 818 funds tracked by Wall St. Rank hold ZBH as of Q3 2017.

Wellington Shields Capital Management reported no remaining Zimmer Biomet position as of Q3 2017 after selling out during the quarter.
Wellington Shields Capital Management sold 15,980 Zimmer Biomet shares in Q3 2017, an estimated $1.99M.
Wellington Shields Capital Management first reported a position in Zimmer Biomet in Q4 2013 and held it in 15 quarters.
Wellington Shields Capital Management's Zimmer Biomet position peaked at $2.26M in Q3 2016.
818 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2017.

Based on Wellington Shields Capital Management's 13F filing for Q3 2017, filed 6 Nov 2017.